Mechanism: In aging, 'phospho-noise' dysregulates selective autophagy receptor (SAR) hierarchy, favoring ER-phagy over mitophagy and causing mitochondrial decline. Readout: Readout: Pharmacological inhibition of TBK1 restores normal SAR hierarchy, improves mitophagy, and increases lifespan by 25%.
Hypothesis: The order in which selective autophagy receptors (SARs) engage the limiting ULK1-FIP200 initiation complex is governed by stress-induced phosphorylation that alters each receptor’s LIR affinity and oligomerization state, creating a competitive, hierarchical triage of cargo. When this phosphorylation-dependent switching is perturbed—either by constitutive activation or loss of the modifying kinase—the hierarchy collapses, leading to misordered organelle degradation and accelerated cellular aging.
Mechanistic rationale: SARs such as p62/SQSTM1, OPTN, and NDP52 share the ULK1-FIP200 platform via their LC3-interacting regions (LIRs) but differ in basal affinity. Post-translational modifications, particularly phosphorylation of residues adjacent to the LIR (e.g., p62 Ser403 by TBK1, OPTN Ser177 by CK2), increase LIR-ATG8 binding and promote PB1-mediated oligomerization, thereby increasing avidity for the initiation complex 1. Under acute oxidative stress, mitochondria-derived ROS sensitize p62’s ZZ domain, favoring mitophagy 4, whereas inflammatory cues rapidly induce OPTN and SEC62, shifting the competitive balance toward ER-phagy 3. These stress-specific PTMs create a temporal window in which one SAR outcompetes others for the limiting ULK1 pool, establishing a degradative hierarchy that mirrors the cell’s survival priorities.
In aging, chronic low-grade inflammation and oxidative stress become dysregulated, causing persistent, sub-threshold phosphorylation of SARs. We predict that this "phospho-noise" biases the hierarchy toward constitutive ER-phagy (via OPTN) at the expense of timely mitophagy, leading to progressive mitochondrial decline—a hallmark of aging. Supporting this, p62 phospho-deficient mutants fail to prioritize mitochondria under stress, while phospho-mimetic variants cause indiscriminate cargo uptake and aggregate formation 2.
Testable predictions: (1) CRISPR knock-in of phospho-null (S403A) p62 in human fibroblasts will delay ER-phagy activation upon TNF-alpha treatment but enhance mitophagy after CCCP, measurable by mt-Keima and ER-phagy reporters 5. (2) Expressing phospho-mimetic OPTN (S177D) will saturate ULK1 binding, suppress p62-mediated mitophagy, and increase mitochondrial ROS in aged mice. (3) Pharmacological inhibition of TBK1 in middle-aged mice will restore the normal phosphorylation oscillation of SARs, re-establish the autophagic hierarchy, and improve locomotor performance and lifespan. Conversely, chronic TBK1 activation will phenocopy accelerated aging markers.
Falsification: If manipulating SAR phosphorylation status does not alter the rates of organelle-specific autophagy or if hierarchy remains unchanged despite PTM edits, the hypothesis would be refuted, suggesting that other mechanisms (e.g., spatial segregation of autophagy initiation sites) dominate hierarchy determination.
Comments
Sign in to comment.